Bullboard - Stock Discussion Forum Kura Oncology Inc KURA

Healthcare Biotechnology

Kura Oncology, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on precision medicine for the treatment of cancer. Its pipeline consists of small molecule product candidates that target cancer signaling pathways. Its product candidates include Ziftomenib, Tipifarnib and KO-2806. Ziftomenib, is a potent, selective, reversible and oral small molecule inhibitor that... see more

Add To Watchlist

NDAQ:KURA - Post Discussion

Kura Oncology Inc > Kura Oncology Receives Breakthrough Therapy Designation for

View:

Post by whytestocks on Apr 22, 2024 1:15pm

Kura Oncology Receives Breakthrough Therapy Designation for

Just In: $KURA Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML– Ziftomenib is the first investigational treatment to be granted Breakthrough Therapy Designation for NPM1-mutant AML – – Registration-directed trial of ziftomenib in NPM1-mutant AML on track to complete enrollment by mid-2024 – SAN DIEGO, April 22, 2024 (GLOB...KURA - Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML